Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms

BACKGROUND: Identification of circulating tumor markers for clinical management in bronchopulmonary (BP) neuroendocrine tumors/neoplasms (NET/NEN) is of considerable clinical interest. Chromogranin A (CgA), a “universal” NET biomarker, is considered controversial as a circulating biomarker of BPNEN....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuroendocrinology
Main Authors: Matar, Somer, Malczewska, Anna, Oberg, Kjell, Bodei, Lisa, Aslanian, Harry, Lewczuk-Myślicka, Anna, Filosso, Pier Luigi, Suarez, Alejandro L., Kolasińska-Ćwikła, Agnieszka, Roffinella, Matteo, Kos-Kudła, Beata, Ćwikła, Jarosław B., Drozdov, Ignat A., Kidd, Mark, Modlin, Irvin M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7472424/
https://ncbi.nlm.nih.gov/pubmed/30995665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000500202
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados